Diana Zuckerman is president of the National Center for Health Research, a nonprofit think tank based in Washington, D.C.
Diana Zuckerman
President
National Center for Health Research
From this contributor
How the new U.S. ‘Right to Try’ law could harm people with autism
People with autism already have access to experimental treatments; the new law could make that access more dangerous.
How the new U.S. ‘Right to Try’ law could harm people with autism
By
Diana Zuckerman
3 July 2018 | 5 min read
Why the 21st Century Cures Act could be disastrous for medicine
A new bill threatens to lower the scientific standards that have made the Food and Drug Administration's approval the gold standard worldwide.
Why the 21st Century Cures Act could be disastrous for medicine
By
Diana Zuckerman
1 December 2016 | 6 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read